Dan Mitchell

Daniel J.
Mitchell was the founder of Capital Health Venture Partners, founded in 1986, where he held the title of General Partner from 1986 to 2006.
He is also the founder of Sequel Venture Partners LLC, founded in 1997, where he currently holds the title of Partner.
Mr. Mitchell's current job(s) include being a Director at Plato BioPharma, Inc., a Director at Bolder Surgical LLC since 2019, a Director at ViroCyt, Inc., a Director at Skyland Analytics, Inc., and a Manager at Sequel Venture Partners III LLC.
Mr. Mitchell's former job(s) include being a Director at Gilead Colorado, Inc., a Director at Replidyne, Inc. from 2002 to 2009, an Independent Director at GlobeImmune, Inc. from 2003 to 2016, a Director at IntelliDx, Inc., a Director at Kalypto Medical, Inc., an Independent Director at ARCA biopharma, Inc. from 2014 to 2024, a Principal at First National Bank of Chicago (Illinois) from 1983 to 1986, and a Member at Excel Medical Ventures LLC.
Mr. Mitchell's education history includes an MBA from the University of California, Berkeley and an undergraduate degree from the University of Illinois.